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Abstract 
Master Thesis, Programme in Medicine 
Effectiveness and adherence to guidelines for prevention of mother to child transmission of 
HIV at KCMC, Moshi, Tanzania 
Maria Lundberg, 2014 
Department of Infectious Diseases, Sahlgrenska University Hospital, Gothenburg, Sweden 
 
Background Mother-to-child transmission (MTCT) is the second most common mode of 
HIV transmission after heterosexual contact. The estimated rate of MTCT without any 
interventions is 25-40% but with the adequate prevention including HIV-testing, antiviral 
treatment and breastfeeding advices the MTCT could be less than 1%. 
Aim To identify factors that influence MTCT of HIV. 
Method An observation study was performed on the adherence among consecutive HIV-
positive mothers to the current guidelines on prevention of MTCT of HIV.  
Results In total 98 HIV-positive mothers with children born between 1998 and 2014 were 
included in the study, 26 of the mothers had a HIV-positive child, 43 had a HIV-negative 
child, 20 had children with unknown HIV-status and 9 were excluded due to insufficient data. 
The transmission rate of HIV during 2014 was 14%. The mothers with HIV-positive children 
had a lower CD4-count than the mothers with HIV-negative children (p=0.003). The mothers 
who were diagnosed after delivery had a higher prevalence of infected children in comparison 
to those who were diagnosed before the pregnancy (p<0.004).  A tendency towards that the 
mothers with HIV-positive children received treatment to a lesser extent than those with HIV-
negative children was seen (p=0.07). The children who acquired the infection also received 
treatment to a lesser extent then the negative children (p<0.001). Nevirapine prophylactic 
treatment to the child had the strongest impact on the MTCT and reduced the transmission 
rate with one fifth. It was also seen that exclusive breastfeeding for six months reduce the 
transmission rate with 43%. 
Discussion and conclusion: This study showed that the rate of MTCT of HIV is strongly 
correlated on the extent of the adherence to the guidelines of prevention. The prevention 
programs of MTCT in the western world today are very effective and to halter the MTCT in 
developing countries the programs must be available and accepted by all pregnant women 
with a high compliance. 
 
Keywords: HIV, prevention, pregnancy, resource limited settings 
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Background 
 
Introduction 
 
Human Immunodeficiency Virus (HIV) continues to be a major global public health issue and 
it is included as one of the ten leading courses to death worldwide defined by WHO [1]. In 
2013 approximately 35.3 million people in the world lived with the disease and Sub-Saharan 
Africa has the highest rate where nearly one in every twenty adults live with the infection [2]. 
One of the targets in the UN Millennium Developing Goal six is to halt the spread of 
HIV/AIDS by 2015 [3] and great achievements have been done but still there is much to do to 
reach this goal. 
 
HIV is a RNA retrovirus witch infects CD4+  helper T –lymphocytes and the virus uses the  
host cell to multiply. When the virus burden increase as the disease develops the amount of 
CD4+ cells decreases through apoptosis. The decrease of CD4-cells enable opportunistic 
infections and/or tumours and the CD4+-count can be used to determine the degree of the 
immunosuppression [4]. 
 
HIV can appear in two different subtypes, subtypes 1 and 2. HIV-2 has remained largely 
restricted to West Africa and the subtype has both lower pathogenicity and transmission rate 
with near complete absence of mother-to-infant transmissions [5]. 
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Treatment of HIV 
Unfortunately there is no available cure for HIV today. Antiretroviral therapy (ART) can be 
used to slow down the replication of the virus and there is also available treatment for some of 
the opportunistic infections and tumors. The first HIV-medicines was developed in the 80th 
but it was first in the 90th they become effective enough to treat the disease with reduced 
mobility and mortality [4]. Today the medicines are very effective and in high-income 
countries half of death are not related to AIDS among HIV-positive patients who receive ART  
[6].  
 
The medicines can be divided into five groups based on theirs pharmacodynamics and they all 
work at different stages in the virus life's cycle. The groups are; entry/fusion inhibitors, 
nucleoside reverse transcriptase inhibitors, for example zidovundin (AZT) and lamivudin 
(3TC), none-nucleoside reverse transcriptase inhibitors, for example efavirenze (EFV) and 
nevirapin (NVP), integrase inhibitors and protease inhibitors. 
 
The standard treatment today is a combination of tree different substances from two different 
groups [4]. This is often called highly active antiretroviral therapy (HAART) [36] or 
combined antiretroviral therapy (cART) and a successful combination can induce a huge 
reduction in the virus burden and enable the immune system to recover [4]. 
 
High adherence to the treatment is very important to control the disease and to minimize the 
risk of developing a therapy resistant infection. As long as a person is on medicine the virus 
cannot infect new cells. Even if one miss out on a small amount of doses it can cause a lower 
serum concentration of the medicine which can make it possible for the virus to start replicate. 
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An increase rate of replication will increase the risk of developing mutation which could 
makes the virus resistant to the treatment and it will also make the person more infective [4]. 
 
Classification of HIV 
Staging and classification systems are critical tools for both tracking and monitoring the 
epidemic and clinical management. Today there are two major classification systems; the U.S. 
Centers for Disease Control and Prevention (CDC) classification system and the World 
Health Organization (WHO) Clinical Staging and Disease Classification System. The WHO 
system was developed in 1990 and it divides the disease into four stages were stage four is the 
most advance stage of the disease. The system is mainly based on clinical symptoms and 
parameters but a positive HIV-antibody test or other laboratory evidence of HIV infection is 
required to be able to use the system [7]. The CDC classification system contains three stages 
and it takes in account the CD4+-count and the 26 AIDS-defining conditions [9]. 
 
United Republic of Tanzania 
 
Tanzania is a Sub-Sahara country and border Indian Ocean in the east. The population is 
estimated to be around 45 million divided into thirty regions and Dodoma is the capital city. 
The country is a democratic republic but one party is dominant and elections is held every 
fifth year. 
 
Tanzania is one of the poorest countries in the world. About half of the population is under 18 
years of age and around three million children are orphans. The population is growing fast 
and the country lack recourses to take care of the growing population. In the country, one 
third lives in poverty and one in five have not enough to eat every day [13].  
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Moshi Municipality is located in the north of Tanzania in the Kilimanjaro Region and the 
population is almost 200, 000. Moshi has one of the highest literacy rate for persons over 15 
years of age in Tanzania [14] it is assumed to be the cleanest town in the country and the 
tourism is very important source of income like export of coffee and tea.  
 
Prevalence of HIV in Tanzania 
The first case of HIV in Tanzania was reported in 1983 in the Kagera Region. Since then the 
prevalence has steady increased until the peak in 1997 when the prevalence was 8% [35]. The 
prevalence among adults today (age 15-45 in 2011-12) is 5.1 % [12] and the number is 
significantly higher in urban regions in comparison to rural areas [8]. Big differences are also 
seen within the country. Iringa Region had the highest prevalence where 15.7 % of the 
population was positive and Kilimanjaro Region, where the study been conducted, had one of 
the lowest prevalence where only 1.9% (age 15-49 in 2011-12)  were positive [14]. 
 
Kilimanjaro Christian Medical Centre and Child Centred Family Care Clinic 
 
Kilimanjaro Christian Medical Centre, KCMC was established in 1971 and it serves daily 
about 1000 outpatients in Kilimanjaro Region. It is a university hospital which has 11 clinical 
departments,  450 beds and offers diagnostic and treatment options for various disease and 
conditions including HIV/AIDS.  
 
The Child Centred Family Care Clinic, CCFCC was started in December 2007. The clinic 
provides care and treatment to both children infected with HIV/AIDS and to HIV-exposed 
children until vertical transmission could be excluded and their families under one roof, this 
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due to the fact that HIV/AIDS are considered to be a family disease. The vision of the clinic is 
to integrate both treatment and care, and the clinic works closely with the social service [15]. 
 
Transmission of HIV 
 
HIV infection can be acquired through sexual intercourse, exposure to infected blood and 
from mother to child during pregnancy, labour, delivery and breastfeeding. Heterosexual 
unprotected intercourse is the main route of spreading the infection both worldwide and in 
Tanzania and more than 90% acquired the infection this way [8]. The transmission probability 
per sex act depends both on the type of intercourse (See Table 1) as well as on the virus 
burden in the infected person [19].  
Table 1. Risk of transmission of HIV due to type exposure and stage of HIV diseases. 
Activity Risk-per-exposure  
Vaginal sex, male-to-female, studies in low-income countries 0.30% (1:333) 
Vaginal sex, female-to-male, studies in low-income countries  0.38% (1:263) 
Vaginal sex, source partner has late-stage disease 0.55% (1:180) 
Receptive anal sex amongst gay men 0.82% (1:123) 
 
During the first weeks of infections the virus burden increases rapidly and the person is highly 
infective. After a couple of weeks the immune system starts responding to the infection and 
the virus burden decreases and stabilizes on a level call "set point" and the person becomes 
less infective. The virus burden will later increase as the disease develops and the person will 
than become more infective again (See Figure 1) [4].  
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                           Figure 1. Viral load and CD4-count in relation to stages of the disease [21] 
 
The infection can also be spread by other body fluids such as genital secretions, cerebrospinal 
fluid and amniotic fluid. Transmission resulting from exposure to saliva, urine or sweat is not 
very likely, if at all possible [8]. The second most common mode of transmission is Mother-
to-child transmission (MTCT) or vertical transmission witch contributes to over 90% of new 
infections in infants and young children [12] and around 20% of the new infection in the 
whole society [33]. Since there is no cure for HIV, primary prevention is the most effective 
means to control the spread and minimise its impact on individuals, families and 
communities. 
 
Mother to child transmission of HIV 
 
A decline is seen in the number of children acquiring HIV infections through MTCT [3] but 
still there is more to be done. With the adequate prophylaxis including HIV-testing, antiviral 
treatment and breastfeeding advices the MTCT could be less than one percent [34] in 
comparison to 20-45% which is the estimated rate of transmission without any prevention  
(See Figure 2) [14].  
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              Figure 2. Estimated rate of transmission of HIV without any prevention. 
 
There are many risk factors that increase the transmission rate during pregnancy, labour, 
delivery and breastfeeding. For example, different kinds of infections and high maternal viral 
load and a low CD4 count (See Table 2, Figure 2) [35].   
Table 2. Risk factors for mother to child transmission of HIV. 
During Pregnancy During Labour and Delivery  When Breastfeeding  
High maternal viral load and 
low CD4 count (new infection 
or advanced AIDS) 
High maternal viral load and low 
CD4 count (new infection or 
advanced AIDS) 
High maternal viral load and low CD4 
count (new infection or advanced 
AIDS)  
Viral, bacterial or parasitic 
placental infections (e.g., 
malaria)  
 
Chorioamnionitis (from untreated 
STIs or other infections)  
Oral disease in the infant (e.g., thrush 
or mouth sores)  
STIs Rupture of membranes for more 
than 4 hours before delivery 
Breast abscesses, nipple fissures, and 
mastitis 
  Long Duration of breastfeeding  
  Mixed feeding (i.e., breastfeeding 
combined with other foods or fluids) 
before 6 months of age  
 
To reduce and minimise the transmission rate Prevention of MTCT-programs (PMTCT-
programs) have been developed. The goal of the PMTCT-programme in Tanzania is virtual 
elimination of MTCT of HIV by 2015. Virtual elimination refers to 90% reduction in 
estimated number of new infants infection and an HIV infants transmission rate of <5%, 
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which is associated with at least 90% of all the HIV-exposed infants being alive and 
uninfected with the virus at the age of 2 years [35].   
 
In Sweden the care of HIV-positive women is very advanced and the guidelines are highly 
implemented. The MTCT rate is lower than 1% [6] and during the past 10 years there is only 
3 reported cases on children required the infection via the mother. These three mothers were 
all assumed to be well treated and at the time following the current national guidelines with 
high compliance. 
 
National Guidelines for Comprehensive Care of Prevention of Mother-to-Child 
Transmission of HIV services in Tanzania 
 
The Ministry of Health and Social Welfare (MoHSW) in Tanzania has been implementing 
PMTCT services in the country since 2000. A scale-up and roll-out was done in 2003 to cover 
all the fourteen regions in the country. In 2004 national guidelines was developed and the 
current guidelines are based on national HIV/AIDS policies and strategies and also on WHO 
recommendations on PMTCT and infant feeding from 2010. Since 2010, in 2013, WHO 
updated theirs guidelines but those changes are not yet implanted in the current guidelines in 
Tanzania. The guidelines today includes; HIV-testing, comprehensive ANC, ART to the 
mother and prophylactic treatment to the child, safe delivery practises, counselling on safe 
infant feeding, postpartum care for mother and infant following-up tests (See Figure 3). 
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Figure 3. Handling of pregnant women at ANC or RCH.  
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HIV-testing 
All women should receive HIV testing with both pre and post-testing counselling at the first 
antenatal visit. A negative test should always be retested during the third trimester and partner 
should also be encouraged to be tested. The diagnosis of a HIV infection in adults is 
established by detecting HIV antibodies using simple rapid tests according to the national 
HIV rapid testing algorithm. The result of the test should always be given to the patient within 
the same day of testing combined whit post-testing counselling regardless of the result.  
 
Women in labour with unknown HIV status should receive a rapid HIV test as it is important 
that ARV prophylaxis can be administered as soon as possible. 
 
All HIV-exposed infants should have an initial PCR HIV-test at the age of 4 to 6 weeks. 
Infants who has a negative first HIV-test will need two repeat HIV-test, one additional PCR-
test at six weeks after complete cessation of breastfeeding and one antibody test (either rapid 
tests or ELISA or a combination of both) at 18 months of age. At 18 month of life the 
antibodies from the mother are assumed to be disappeared and the antibody tests can be 
reliably used to diagnose the infection in the same manner as in adults.  
 
Antenatal care 
Pregnant women living with HIV should attend ANC clinic every month to ensure high 
adherence to treatment. The visits should also include a full delineation of the women health 
situation with physical examinations, laboratory testing, HIV-staging, counselling on 
PMTCT, healthy delivering and infant feeding advices, ART or ARV and vaccinations. 
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The women should be offered cotrimoxazole 960mg daily through the pregnancy to reduce 
the risk of getting any opportunistic infection or other infections during the pregnancy. 
The women should also receive nutritional counselling throughout the antenatal period and  
nutritional supplements if needed. Before discharge from the labour ward the mother should 
be administered vitamin A. 
 
Antiretroviral treatment to mother and child  
Antiretroviral treatment (ART) is used both to treat the maternal infection and to reduce the 
risk of transmission from the mother to the infant. Treatment to the mother reduces related 
morbidities which improves the survival chances of the child and it also decreases the viral 
load in the mother which reduces the infant’s exposure to HIV with results in a reduced in the 
risk of acquire the infection. 
The eligibility for ART can be determined by clinical staging or by the CD4-count. If the 
pregnant woman is eligible for treatment it should start as soon as possible and continue 
throughout pregnancy, childbirth, breastfeeding and thereafter. If a woman already is on ART 
the regular dosing schedule should continue throughout labour and delivery, as well as during 
the postpartum period. In some cases there is a need to change the medications. For example, 
efavirenz should not be used during the first trimester because it may causes birth defects and 
nevirapine regimes should then be used instead. 
 
Eligibility criteria for ART to a pregnant women living with HIV; 
• CD4 cell counts of ≤350 cells/mm3, irrespective of WHO clinical staging or 
• WHO clinical stage 3 or 4, irrespective of the CD4 cell count. 
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The first line of ART regimes is AZT + 3TC + EFV or AZT + 3TC + NVP. The treatment 
should always be coupled with once daily administration of NVP to infants from birth or as 
soon as possible and thereafter until 6 weeks of age, regardless of infant feeding choice. 
 
Women not eligible for ART should receive or antiretroviral prophylaxis (ARV)  with AZT 
300 mg twice a day from as early as 14 weeks of gestation and no postpartum treatment is 
assumed to be needed in those cases. This treatment should as well always be coupled with 
daily administration of NVP to infants from birth or as soon as possible and thereafter until 6 
weeks of age, regardless of infant feeding choice. (See Figure 5).   
 
Implementation of safer obstetric practices 
Safe obstetrics includes; using standard precautions, minimise vaginal examinations, avoiding 
prolonged labour and unnecessary trauma during delivery, misnaming the risk of postpartum 
haemorrhage and using safe transfusion practices. 
 
Caesarean section performed before the onset of labour or membrane rupture has been 
associated with reduced MTCT. However, in Tanzania, the capacity to perform caesarean 
sections is low and it is not recommended for the purpose of reducing MTCT. The only 
indicated for caesarean section should be obstetric reasons. 
 
Healthcare workers should strongly encourage all women to give birth at facilities where 
skilled health care workers can address potential complications and provide care that will 
reduce the risk of MTCT. 
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Infant feeding 
Mothers wishing to reduce the risk of transmitting HIV to their infants should either choose to 
exclusive replacement feed their infants or breastfeed exclusively for the first 6 months of life. 
However, exclusive replacement feeding is only recommended when it is assumed to be 
AFASS (acceptable, feasible, affordable, sustainable and safe) (See Table 3). The current 
general advice is therefore to breastfeed exclusively for the first six months of life and then 
introduce complementary foods while continuing to breastfeed to 12 months of life. The child 
should be receiving ARV prophylaxis for 6 weeks regardless of feeding option. If the child is 
confirmed as HIV-positive the mother are recommend to breastfeed the child until 24 months 
of age [35].  
Table 3. Definitions of different infant feeding options. 
Exclusive breastfeeding = Feeding infant ONLY  breastmilk and no other liquids or solids, 
with the exception of drops or syrups consisting of vitamins, mineral supplements or 
medicines prescribed by a healthcare worker.  
Replacement feeding = Feeding infant something OTHER THAN breastmilk. During the first 
6 months of life, the only replacement feed that meets an infant’s nutritional requirements is 
commercial infant formula.  
Mixed feeding = Feeding both breastmilk and other liquids (such as water, tea, formula, 
animal milk) or foods (such as porridge or rice). 
 
New guidelines for prevention of MTCT from WHO  
 
The greatest differences between the recommendations from WHO 2010 and 2013 are 
regarding the treatment to the mother. In the guidelines from 2013 it is recommend that 
countries follow option B+ and in countries where this is not feasible, option B should be 
applied. Option A is now only cited as a last resort (See table 4). As writing there is an 
ongoing work in implanting the new guidelines from WHO in the daily work at CCFCC. 
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Table 4. Treatment options for pregnant HIV-positive women. 
Option B+: A triple-drug antiretroviral regimen which should be taken throughout 
pregnancy, delivery, breastfeeding and continuing for life, regardless of CD4 count or 
clinical stage.  
Option B: A triple-drug antiretroviral regimen should be taken throughout pregnancy and 
delivery. If the mother is breastfeeding, she should also continue to take the triple-drug 
antiretroviral regimen up to 1 week after breastfeeding has finished.  
Option A: One antiretroviral regime with AZT daily during pregnancy and one week post-
partum. 
 
Efavirenz should today be one of the three drugs in the first line regime regardless of 
trimester. This due to the fact that it can be used in all women, regardless of CD4 count unlike 
nevirapine, which cannot be used in women with high CD4 counts because of the risk of serve 
side effects. Although concerns remain about the safety of efavirenz in early pregnancy but 
the benefits are likely to outweigh the risks [16, 17]. 
 
Another difference from the old recommendations is the view on co-trimoxazole as 
prophylactic treatment against various infections. The recommendations today are stricter and 
co-trimaxazole should only be used when the HIV disease is severe (WHO clinical stage 3 
and 4, or CD4 ≤350 cells/mm3) and in settings with high prevalence of malaria and/or severe 
bacterial infections regardless of WHO clinical stage or CD4 cell count [18].  
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Aim 
 
• To investigate the adherence among HIV-positive mothers to the current guidelines for 
PMTCT of HIV in Tanzania. 
• To investigate the effectiveness of the current guidelines for PMTCT of HIV in 
Tanzania. 
• To investigate the knowledge about HIV/AIDS among HIV-positive mothers in 
Tanzania.  
 
Methods 
 
The study took place at CCFCC, KCMC during 11 weeks in October to December, 2014.  
 
Study design 
 
The study was conducted as an empirical observation study of the adherence among HIV-
positive mothers to the current guidelines of PMTCT of HIV in Tanzania. The study had a 
positivistic view with quantitative gathering of data. The data was collected via 
questionnaires. The questionnaire was prepared on forehand in Sweden and presupposed from 
the current guidelines in Tanzania. The questions were later translated from English into 
Swahili  by two fifth year medical students at KCMC. To prevent misunderstandings the 
questions were initially tested on a pilot group of ten mothers and then slightly improved. The 
questionnaire was handed out to the mothers during the concealing meeting that was held by 
three different nurses at the clinic every morning. The mothers mainly filled in the 
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questionnaire by themselves but I or one of the three nurses were available at all time if any of 
the mothers needed clarifications or help with reading or writing. 
 
Study population 
 
The sample consisted of 98 consecutive HIV-positive mothers at CCFCC.  
 
Variables in the study 
 
Data was abstracted in the questionnaires regarding; 
• General information about the mother including age, number of children, marital 
status, living condition, location of residence, level of education and profession. 
• Specific information about the mother including number of HIV-test, time of 
diagnosis, CD4-count, duration and type of treatment. 
• Adherence and compliance to treatment and recommendation regarding PMTCT of 
HIV among the mothers. 
• Knowledge about HIV/AIDS among the mothers regarding routes of transmission, 
prevention of transmission, infant feeding and prevalence as well as where the mother 
had get the most useful information and from where they wish to get more.  
• Regarding the child; age, HIV-status and management.   
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Statistical methods  
 
Data analyses were done using Microsoft Office Excel 2007. Comparisons between groups 
were performed using Fisher´s exact test if n>5 otherwise chi square tests were used. T-test 
were used to compare mean values. P values <0.05 were considered statistically significant.  
 
Ethical considerations  
 
The clients were informed in Swahili that participation in the study was voluntary. They were also 
informed that whether or not they chose to participate, the treatment at the clinic would not be 
affected. Neither the mothers nor the children in the study are able to identify. The clients had to 
sign a consent form (See appendix 1) before the start of the participation in the study and the 
consent form will not be a part of further analysis.  
 
Ethical approval was obtained from Kilimanjaro Christian Medical College and University Ethical 
Committee. 
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Results 
 
Epidemiology 
In total 98 mothers was included in the study, 26 mothers had a HIV-positive child, 43 had a 
HIV-negative child, 20 mothers had a child with unknown HIV-status and 9 were excluded 
due to insufficient data.  The median age of the mothers was 35 years. The mothers to the 
HIV-positive children had a median age of 38 years and the mothers of the HIV-negative 
children had a lower median age, 33 years (p=0.002). In total 40% of the mothers were 
married but the prevalence of widows was higher among the mothers with HIV-positive 
children in comparison to the mothers with HIV-negative children (p=0.03). Only one third of 
the mothers had told their partner about their HIV-status and there was one mother how have 
not told anyone in her surrounding about her HIV-status. Almost half of the mothers lived in 
rural area and the other half in urban areas. A trend was seen that it was more common among 
the mothers with HIV-positive children to live in rural areas but this was not statistically 
significant. Almost all, 87/89 (98%) of the mothers had been to school. The majority had went 
to primary or secondary school and only 9/89 (10%) had a university degree (See Table 5). 
Table 5. Epidemiology of the mothers.  
Characteristics Mothers with HIV-positive 
children 
Mothers with HIV-negative 
children 
P-
value 
Total 
Median age, years 38 (n=25) 33 (n=44) 0.002 35 
Number of children, average 2 2  2 
Married 8/26 (31%) 22/43 (55%) - 36/89 
(40%) 
Widows 8/26 (31%) 2/43 (5%) 0.03 4/89 
(4%) 
Location of residence, urban 
area 
8/26 (31%) 22/43 (51%) 0.42 41/87 
(47%) 
Location of residence, rual 
area 
15/26 (58%) 20/43 (47%) 0.42 41/87 
(47%) 
Went to primery or 
secondery school 
25/26 (96%) 36/44 (82%) - 87/89 
(98%) 
Went to high school or 
university 
3/26 (12%) 3/44 (7%) - 9/89 
(10%) 
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The median age of the children was 4 years, range 0-16 years, and the mothers had in average 
two children. The children were in average born in week 37 and 34% of the children were 
delivered via caesarean section. Almost all of the children, 88% were born at a hospital or 
health care centre and no statistically significant difference was seen neither in location of 
birth or way of delivery between the children how acquired the infection or not (See Table 6). 
Table 6. Epidemiology of the children. 
Characteristics  
Median age, years 4 (0-16) 
Median delivery week 37 
Caesarean section  27/80 (34%) 
Delivery at hospital/health care centre 67/76 (88%) 
  
 
Knowledge about HIV/AIDS among the mothers 
 
The median age for when the mothers first had heard about the disease HIV/AIDS was 23 
years and no statistically significant differences was seen between the mothers with HIV-
positive and HIV-negative children (See Figure 4).  
 
Figure 4. Age of the mothers for when they first heard about HIV/AIDS.  
 
More than half of the mothers, 40/75 (53%) believed that the prevalence in the area where 
they lived were higher than 50% and only seven mothers, 7/75 (9%) estimated correctly the 
prevalence to be between 1-10% (See Table 7). 
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Table 7. Knowledge among the mothers.  
 Percents, %, of the mothers 
Estimate the prevalence to >50% 53 (40/75) 
Estimate the prevalence to 1-10% 9 (7/75) 
Awareness of transmission modes of HIV  
              Sexual intercourse  98 (86/88) 
              Hetorsexual intecourse as the main route of transmission 87 (62/71) 
              Mother to child transmission 55 (48/88) 
              Breastfeeding  38 (33/88) 
Awareness of prevention modes for MTCT of HIV  
              Treatment to mother 41 (35/85) 
              Treatment to child 33 (28/75) 
Believed there is a cure of HIV/AIDS 29 (24/83) 
Available treatment for HIV/AIDS 65 (56/86) 
 
Almost everyone of the mothers, 86/88 (98%) knew that HIV could be spread via sexual 
intercourse whiteout condom and 62/71 (87%) knew that unprotected heterosexual intercourse 
was the main mode of transmission in the area they were living in.  
 
The level of knowledge regarding PMTCT was very low. Only 48/88 (55%) knew that HIV 
can be spread from mother to child during pregnancy and delivery and only 33/88 (38%) 
mothers knew that it can be spread via breastfeeding. Less than half of the mothers, 35/85 
(41%) knew that medicine to the mother could prevent the transmission and 28/75 (33%) 
mothers knew that medicine to the child could prevent transmission.  
 
One in every third mother, 24/83 (29%) believed that there is a cure for HIV and only 56/86 
(65%) mothers knew that there is available treatment with reduction and prevention of related 
symptoms. 
 
Half of the mothers, 39/83 (47%) reported that they got the most useful information about the 
disease from the health care system and 62/81 (77%) reported that they would like to get more 
information about the disease from the health care system. 
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No statistically significant differences were seen between the mother with HIV-positive and 
the mothers with HIV-negative children in the level of knowledge regarding general 
knowledge and routes and prevention of transmission of HIV/AIDS. 
 
Effectiveness and adherence to the guidelines for PMTCH of HIV 
 
The mothers with a HIV-positive children had a lower CD4-count in comparison to those with 
HIV-negative children (398 versus 628, n=22, p=0.003). 
 
The transmission rate of HIV from the mother to the child during 2014 at CCFCC was 4/22 
(14%) and 1/11 (9%) during 2013 (See Figure 5). 
 
Figure 5. The number of HIV-positive and HIV-negative children at CCFCC 1998-2014. 
 
In those four cases where transmission occurred during 2013-14, one child was premature, 
one mother was diagnosed during the pregnancy, had a low CD4-count and low adherence to 
the ART, one was diagnosed after the delivery and one reported low adherence to the ART 
and prematurity as risk factors for transmission (See Table 8). 
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Table 8. Reported risk factors for vertical transmission among the mothers-child pair were the transmission 
occurred 2013-14. 
 Time of 
diagnos 
CD4-count Treatment Delivery Prophylactic 
treatment to  
the child 
Exclusive 
breastfeeding, 
6 months 
Mother I Before 
preagnancy 
 Stated before 
preagnancy  
High adherence 
Week 32 
Caesarean 
section 
NVP, 6 weeks  Yes 
Mother 2 Week 28 163 Started in w 28 
Low adeherence 
Week 38 NVP, 6 weeks  Yes 
Mother 3 After delivery 353     
Mother 4 Before 
preagnancy 
 Started before 
preagnancy  
Low adeherence  
Week 36 NVP  Yes 
 
HIV-testing of mother and child, and times of diagnosis of the mothers 
The mothers had in average 2.7 HIV-tests in their life and no differences were seen between 
the mothers with HIV-positive and HIV-negative children. It could though be seen that the 
mothers with HIV-positive children was diagnosed later than the mothers with HIV-negative 
children. Among the mothers with HIV-positive children 10/25 (40%) where diagnosed after 
delivery but only 2/43 (5%) of the mothers HIV-negative children (p=0.004). It could also be 
seen that diagnosis before pregnancy reduced the transmission rate of HIV to 65% (RR=0.65, 
95% CI 0.25-0.84) (See Table 9).  
 
All children in the study had been offered at least one HIV-test. 
Table 9. Risk factors for mother to child transmission of HIV. 
  Mothers to HIV-positive 
children 
Mothers to HIV-negative 
children 
P-
value 
Risk ratio  
CD4-count, mean value 398 (n=9) 628 (n=13) 0.003  - 
Location of residence, urban area 8/26 (31%) 22/42 (51%) 0.42  - 
Location of residence, rural area 15/26 (58%) 20/42 (47%) 0.42  - 
Diagnosis before pregnancy 11/25 (44%) 32/43 (74%) 0.01 0.65  
(95% CI 0.25-0.84) 
Diagnosis after delivery 10/25 (40%) 2/43 (5%) 0.004 3.11  
(95% CI 1.89-5.14) 
Recived generall advices 
regarding HIV/AIDS 
18/24 (75%) 41/41 (100%) 0.001 0.31  
(95% CI 0.2 -0.45) 
Treatment to mother 21/25 (81%) 38/43 (89%) 0.07 0.8 
 (95% CI 0.36-
1.80) 
Delivery via caesarean section 6/24 (25%) 18/42 (43%) 0.17 - 
Exclusive breastfeeding for six 
months 
17/21 (81%) 42/44 (95%) 0.08 0.43  
(95% CI 0.22-0.87) 
Prophylactic treatment to the 
child 
4/19 (20%) 19/20 (58%) <0.00
01 
0.19 (95% CI 
0.075-0.46) 
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Antenatal care and safer obstetric practices 
As shown in the table 8, delivery via caesarean section tend to be more common among the 
mothers with HIV-negative children in comparison to the mothers with HIV-positive children, 
18/42 (43%) versus 6/24 (25%) but this difference turned out to be not statistically significant 
(p=0.17). 
 
Antiretroviral and prophylactic treatment to mother and child 
A tendency was seen that ART were more common among the mothers with HIV-negative 
children that among the mothers with HIV-positive children, 38/43 (89%) versus 21/25 
(81%), (p=0.07) (See table 8).  
 
Prophylactic treatment with neverepine daily to the child for the first sex weeks of life were 
more common among the HIV-negative children than among the HIV-positive children. 
Among the HIV-positive children, 4/19 (21%) had received prophylactic treatment and 19/20 
(95%) among the HIV-negative children (p<0.0001). Prophylactic treatment to the child had 
the strongest impact on the transmission rate of HIV. The treatment reduce the risk of 
transmission from the mother to the child to 19% (RR=0.19, 95% CI 0.01-0.46). 
 
Infant feeding 
A tendency towards that exclusive breastfeeding for six months were more common among 
the mother with HIV-negative children than among the mothers with HIV-positive children 
was seen. Among the mothers with HIV-negative children, 42/44 (95%) were breastfeeding 
exclusive but only 17/21 (81%) among the mothers with HIV-positive children (p=0.08). 
Exclusive breastfeeding reduced the rate of transmission of HIV from the mother to the child 
with 43% (RR=0.43, 95% CI 0.22-0.87). 
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Discussion 
 
The results in this study shows that there is a strong relationship between the adherence to the 
guidelines for prevention of MTCT of HIV and the transmission rate of HIV from the mother 
to the child during pregnancy, labour, delivery and breast feeding.  
 
The transmission rate of HIV from the mother to the child during 2014 at CCFCC in this 
study was 14% and 9% in 2013. In an earlier survey in Kilimanjaro Region where 561 HIV-
exposed children were followed in regard to the PMTCT components provided the 
transmission rate of HIV between January 2009 and August 2012 was 9.6% [22]. This 
findings can be compared with other related studies on HIV transmission rate in other 
PMTCT programmes. A study in Angola showed a MTCT rate of 1.5% (1/66) [24] and 
another study in Guangdong province in China showed a rate of 6.7% [23]. Both studies were 
executed before the 2013 WHO recommendations. In a study from Côte d'Ivoire the 
transmission rate was as high as 16.1%  even though the mothers received treatment 
according to the PMTCT programme [25]. In Sweden the transmission rate is as low as 0.6% 
when looking at all exposed children in the country between 1999-2003 [26]. As seen, the 
transmission rate differs in those studies between 0.6-16% even though all the mother-
children pairs were including in preventions programmes. This difference can be due to the 
fact that it is hard to accomplish high adherence in resource limited settings to all the steps 
within the programmes which is necessary to reach a low transmission rate. It can also be due 
to the fact that the programmes are less advance in resource limited settings, for example 
replacement infant feeding is not the general recommendation in Tanzania which it is in 
Sweden and also the treatment recommendation varies between countries. 
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First, diagnosis of the mother. It was seen in this study that it was more common with 
diagnosis of the mother after the delivery among the mothers with HIV-positive children than 
among the mothers with HIV-negative children. Diagnosis before pregnancy reduced the 
transmission rate to 65% and it is of course an essential step in the prevention of the 
transmission of the infection. It has earlier been seen that that most vertically infected children 
are transmitted through lost preventive opportunities [37]. 
 
Secondly, treatment to the mother were slightly less common among the mothers with HIV-
positive children than among the mothers with HIV-negative children. In total 87% of the 
mothers did receive treatment and treatment seems to reduce the transmission rate but this 
could not be shown as statistically significant, probably due to the limited sample size in the 
study. In the study in Kilimanjaro Region [22], 93% of the mothers received treatment and a 
strong association was then seen between treatment and reductions of infection in the 
children. This findings have also earlier been seen in many studies, for example in Angola 
were no ART to the mother were associated with a 5-fold higher infant risk of HIV 
transmission or death (3).  
 
Another problem discovered in this study is that the latest recommendation for PMTCT 
treatment to the mother is not implemented in the current national guidelines. The guidelines 
in Tanzania was developed in 2012 and based on the WHOs recommendations from 2010. In 
June 2013 WHO updated their recommendations for antiretroviral treatment to HIV-positive 
mothers and those recommendations are unfortunately not yet implanted in the national 
guidelines in Tanzania. However, there is an ongoing work in implanting the new guidelines 
in the daily work in clinics around the country including at CCFCC. Studies are pointing on 
that the new guidelines both has a positively impact on the health and being cost-saving. A 
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cohort study from Zambia on 600, 000 pregnant women from March 2014 suggest that the 
shift from 2010 Option A to the 2013 guidelines would result in a 33% reduction of the risk of 
HIV transmission among exposed infants. The study also suggest that it would be cost-saving 
in the long term as it spares future treatment costs by preventing infections in infants and 
partners [27]. 
 
Thirdly, treatment to the child turned out to have the greatest impact on the MTCT of HIV in 
this study. It was seen that 60% of the children received prophylactic treatment and it was 
more common among the HIV-negative children than among those how acquired the infection 
(p<0.001). Prophylactic nevirapine daily to the child for six week reduce the transmission rate 
to one fifth in the study. According to a Cochrane review from 2014 based on seven RCT 
antiretroviral treatment to is efficacious in reducing HIV transmission [28].  
 
Fourthly, exclusive breast feeding for six months also had a strong impact on the transmission 
rate of HIV in the study. A tendency towards that exclusive breast feeding were more 
common among the HIV-negative children than among the HIV-positive children was seen 
and in total 91% of the children were exclusive breast fed. In the survey from Kilimanjaro 
Region [22],  it was seen that 89% of the children were exclusive breastfed and that it tended 
to reduce the MTCT but without being statistically significant. The effectiveness of exclusive 
breast feeding has though been seen in many other studies before. In a study from Nigeria, 
more than 80% of exposed babies screened for HIV were breastfed, but the risk of MTCT was 
50% higher for children who were given mixed feeds than for those who were exclusively 
breastfed or given replacement feeding [29] and similar results are seen in studies from 
Ethiopia [30]. 
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It was also shown in the study that the general knowledge about HIV among the mothers was 
surprisingly low. It was seen that the median age among the mother for when they first heard 
about HIV was 23 years. In Tanzania, the mean age for sexual debut was 16.5 and 17.0 years 
of age for respectively males and females and no contraceptive use was reported by 29.7% of 
the males and 40.3% of females [31]. Heterosexual contact is the main route of transmission 
the infection in the country and primary preventions is an essential step in the process to stop 
the spread of HIV. 
 
The level of knowledge regarding PMTCT of HIV was also seen to be very low. For example  
only 55% of the mothers knew that HIV could be spread from mother to child during 
pregnancy, labour and delivery and only 38% knew that it could be spread while breast 
feeding. Only 41% knew that treatment to the mother could prevent MTCT and only 33% 
knew that treatment to the child also could prevent transmission. This is lower in comparison 
to what have been seen in other studies. In a study in Dar es Salaam published in 2013 on 383 
pregnant women in a peri-urban area a higher level of knowledge was seen. For example, a 
majority of the respondents, 96.3% were aware of the possibility of an infected pregnant 
woman transmitting infection to her unborn child [32]. 
 
One third of the mothers also believed that there is a cure for HIV/AIDS. 
 
No differences were seen between the mothers with HIV-positive and the mothers with HIV-
negative children regarding the knowledge about HIV/AIDS. If the general knowledge was 
high among the mothers this would have been a desirable result but since it is rather the 
opposite this is quite stunning. This due to the fact that the mothers with HIV-positive 
children meets an doctor at CCFCC every second month until the child is around 16 years old 
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and regularly attending counselling meetings held by the nurses at the clinic which does not 
exist at the regular HIV-clinic for adults at KCMC. This actions was expected to result in a 
higher awareness among the mothers at the clinic.  
 
Limitations and methodological considerations 
 
An obvious bias in this study is of course recall bias. Over time it is easy to forget and 
remember thing incorrectly. Both the mothers and the children where transmission occurred 
were older which may enhance the recall bias in that group. The guidelines and 
recommendations has also been modified over time with also could enhance the bias among 
the mothers with HIV-positive children. 
 
Another potential bias is the risk of the participants not being completely honest in their 
replies. This regarding two aspects, both due to that clients does not want to admitted that 
they missed dozes or not followed the recommendation as they were supposed to or due to 
that they are afraid of the consequences if the child had acquired the disease. To avoid this the 
clients was on forehand informed that the study was confidential and that it would not affect 
their visit at the clinic in any manner. 
 
The questionnaires was made in English on forehand and translate into Swahili on arrival by 
two fifth year medical students at KCMC witch of course could lead to misinterpretations. 
However, I or one of the three nurses involved in the study was always available for 
clarifications of any kind. 
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Another weakness with the study is that it only contains reported information. The study 
would have been more reliable and broader if it was combined with information from the 
mother files regarding for example duration and type of treatment, CD4-count and year of 
diagnosis. Due to different circumstances this was impossible. In the future it would be 
interesting to compare data from the files with reported data from the clients.  
 
The sample size was offend too small to get statistically significance when small differences 
was seen. Another problem with the sample is that it is only possible to count the 
transmissions rate two years back due to the fact that the HIV-negative children after that 
becomes discharged from the clinic. 
 
Conclusion 
 
This study showed that the rate of MTCT of HIV is strongly correlated on the extent of the 
adherence to the guidelines on prevention of MTCT. The transmission rate was shown to be 
quite high at CCFCC which means that there is room for improvement. It was seen that 
prophylactic treatment to the child and safe infant feeding significantly reduced the 
transmission rate. It was also seen that in those cases were transmission occurred the mother 
were diagnosed later, had a lower CD4-count and had received treatment in a lesser extent in 
comparison to those who had HIV-negative children. 
 
To reach the goal to virtual elimination of MTCT of HIV by 2015 established by MoHSW all 
women in Tanzania must be including in the prevention programmes with a high adherence as 
well as that the new guidelines from WHO must fully be implemented.  
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Populärvetenskaplig sammanfattning 
 
Utvärdering av mor-barn-överföringen av HIV i Tanzania 
 
I studien på 98 HIV-positiva mödrar i norra Tanzania under hösten 2014 sågs det att man 
kunde minska överföringsfrekvensen av HIV från mor till barn med en femtedel via att enbart 
ge smittförebyggande behandling till det nyfödda barnet under dess första sex levnadsveckor. 
Det sågs även att man kraftigt kunde reducera överföringsfrekvensen via att enbart ge 
amningsråd till de nyblivna mödrarna. 
 
HIV är ett av vår tids största hälsoproblem. Ungefär 35 miljoner människor i världen lever 
med sjukdomen och förekomsten är som högst i Afrika söder om Sahara där nästan var 
tjugonde person är drabbad.  I dagsläget finns ingen botande behandling för sjukdomen vilket 
gör arbetet med att minska spridningen till ett essentiellt steg i begränsandet av sjukdomen. 
HIV sprids via samlag, från mor till barn under graviditet, förlossning och amning samt via 
blod. Överföringsfrekvensen från mor till barn i västvärlden är mindre än en procent om man 
följer de rådande rekommendationerna från WHO som bland annat innehåller 
tillvägagångssätt för diagnostisering av modern, behandlingsråd till både mor och barn samt 
riktlinjer för förlossning och amning. Utan några interventioner ligger överföringsfrekvensen 
mellan 25-45%.  
 
Överföringsfrekvensen under 2014 var enligt studien 14% och det sågs att de rådande 
rekommendationerna i många fall inte följdes. Tillexempel, 17% diagnostiserades först efter 
födseln, 14% av mödrarna fick ingen behandling och 36% uppgav att de inte tagit 
behandlingen enligt förskrivningen, 40% av barnen fick ingen smittförebyggande behandling 
och 10% ammades på ett icke önskvärt sätt. Sammantaget bidrog detta till den höga 
överföringsfrekvensen sedd i studien. 
 
För att i framtiden minska sjukdomsbördan till följd av HIV måste nu handläggandet av de 
HIV-positiva mödrarna drastiskt förbättras i Tanzania. Samtliga kvinnor måste få ta dela av 
de rådande rekommendationerna med en hög följsamhet. Tidigare studier har visat att det är 
både hälsofrämjande och ekonomisk gynnsamt för ett land att implementera de senaste 
rekommendationerna från WHO på ett effektivt sätt.  
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Appendix  I 
 
UTAMBULISHO 
Habari. Jina langu ni..................................... mtafiti /muuguzi / muuguzi  ninayefanya kazi 
KCMC/KCMU-College. Tunafanya utafiti tukishirikiana pamoja KCMU-COLLEGE /KCMC na chuo cha 
Gothenburg. Utafiti huu unaangalia uzingatiaji wa miongozo mipya ya kumkinga mototo dhidi ya 
maambukizi ya vvu.  
Katika utafiti huu tungependa kukuhoji kuhusu huduma na ushauri uliopata kuhusu kumkinga 
mwanao dhidi ya maambukizi kulingana na miongozo mipya ya wizara ya afya na shirika la afya 
duniani. Lengo ni kupambanua mapungufu na mafanikio katika miongozo hii ilituweze kutoa 
mapendekezo ya kuiboresha na hivyo kufanikisha zaidi lengo kuu ambalo ni kukinga watoto wote 
dhidi ya maambukizi kwanjia ambazo nisahihi, rahisi na za kueleweka na kukubalika. 
Taarifa utakazotupa katika mahojiano haya zitabaki kuwa siri kati yako na watafiti na zitatumika kwa 
lengo la kujifunza na kuboresha huduma. Wewe binafsi wala mwanao hamta tajwa katika 
kumbukumbu za utafiti huu na taarifa unazotupa hazita athiri huduma mnayo stahili kwa namna 
yoyote ile mbaya.  
Kushiriki ni hiari na unaweza kutoka kwenye kuhusika na utafiti muda wowote, bila ya kubadili haki 
yako ya kupata huduma kwenye kliniki hii. Tungependa sana ushiriki na uwe huru kwenye kushiriki 
maana taarifa zenye usahihi zinazokusanywa kwa watu kama wewe ndio zimewezesha utaalamu wa 
kutoa huduma na jinsi tunavyoendelea kupata taarifa ndivyo huduma zinavyoweza kuboreshwa zaidi, 
kwako binafsi nahata kwa wengine ambao watahitaji huduma baada yako.   
 
TAMKO 
Nimeeleweshwa kikamilifu kuhusu mtoto wangu kushiriki katika utafiti huu pamoja na athari na 
mazuri yake. Ninakubali kwa hiari kushiriki kikamilifu katika utafiti huu kwa faida ya afya ya watoto 
kama nilivyoelekezwa.  
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